SML2248

SK-216

≥98% (HPLC)

• Synonym(e): 2-[5-[[6-[5-(1,1-Dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]-propanedioic acid sodium salt, SK 216, [5-[[6-[5-(1,1-dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]-propanedioic acid disodium salt
• Empirische Formel (Hill-System): C₂₉H₂₉NNa₂O₆
• CAS-Nummer: 654080-03-2
• Molekulargewicht: 533.52
• UNSPSC-Code: 12352200

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: powder
• Lagerbedingungen: desiccated
• Farbe: white to beige
• Löslichkeit: H₂O: 0.5 mg/mL, clear (warmed)
• Lagertemp.: room temp
• SMILES String: CC(C)(C)C(C=C1)=CC2=C1OC(C3=CC=C4C(C=CC(OCCCCCC(C([O-])=O)C([O-])=O)=C4)=C3)=N2.[2Na+]
• InChI: 1S/C29H31NO6.2Na/c1-29(2,3)21-11-13-25-24(17-21)30-26(36-25)20-9-8-19-16-22(12-10-18(19)15-20)35-14-6-4-5-7-23(27(31)32)28(33)34;;/h8-13,15-17,23H,4-7,14H2,1-3H3,(H,31,32)(H,33,34);;/q;2*+1/p-2
• InChIKey: YYTGMMYYLGKWIK-UHFFFAOYSA-L

Beschreibung

Biochem./physiol. Wirkung

SK-216 is an orally active potent and selective inhibitor of Plasminogen activator inhibitor-1 (PAI-1) that inhibits tumor progression and angiogenesis. SK-216 inhibits migration and tube formation of cultured human umbilical vein endothelial cells induced by various angiogenic factors. SK-116 prevents a formation of gastro-intestinal polyps in Min mice.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable